삼성서울병원

Ko En

방사선종양학과 유규상 교수

진료분야
대장암, 비뇨기암, 육종, 피부암, 다발성골수종, 양성종양, 특수방사선치료
진료일정 03 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2021.08 성균관대학교 의학대학원 졸업 (의학박사)
2013.02 성균관대학교 의학전문대학원 졸업 (의무석사)
2008.02 서울대학교 자연과학대학 물리학과/생물학과 졸업 (이학사)

경력

경력
2020.03 ~현재 삼성서울병원 방사선종양학과 임상조교수
2018.03 ~ 2020.02 삼성서울병원 방사선종양학과 임상강사
2014.03 ~ 2018.02 삼성서울병원 방사선종양학과 전공의
2013.03 ~ 2014.02 삼성서울병원 인턴

학회활동

학회활동
2019.01 ~ 현재 대한간암학회 정회원
2018.03 ~ 현재 대한방사선종양학회 정회원
  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-90065-1 Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma Lee1, JH; Yoo, GS; Yoon, YC; Park, HC; Kim, HS
    View PubMed
  • CELLS 2021 10.3390/cells10030554 Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
    View PubMed
  • CLIN MOL HEPATOL 2021 10.3350/cmh.2020.0095 Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study Yoo1, GS; Ahn, WG; Kim, SY; Kang, W; Choi, C; Park, HC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-82177-5 Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
    View PubMed
  • J BREAST CANC 2020 10.4048/jbc.2020.23.e66 Survival and Prognostic Factors for Breast Cancer Patients with Regional Oligo-Recurrence Baek1, JY; Choi, DH; Park, W; Kim, H; Cho, WK; Yoo, GS
    View PubMed
  • CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02794-3 Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab Kim1, N; Yu, JI; Park, HC; Yoo, GS; Choi, C; Hong, JY; Lim, HY; Lee, J; Choi, MS; Lee, JE; Kim, K
    View PubMed
  • CANCERS 2020 10.3390/cancers12092395 Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter? Yoo1, GS; Il Yu, J; Park, HC; Hyun, D; Jeong, WK; Lim, HY; Choi, MS; Ha, SY
    View PubMed
  • INT J COLORECTAL DIS 2020 10.1007/s00384-020-03701-z Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection margin Baek1, JY; Yu, JI; Park, HC; Choi, DH; Yoo, GS; Lee, WY; Yun, SH; Cho, YB; Park, YA; Kim, HC; Nam, H
    View PubMed
  • CANCERS 2020 10.3390/cancers12051300 Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma Yu1, JI; Park, HC; Yoo, GS; Paik, SW; Choi, MS; Kim, HS; Sohn, I; Nam, H
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.261 Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY
    View PubMed

해당하는 결과가 없습니다.